Veradermics, Incorporated (NYSE:MANE) was among the stocks Jim Cramer looked at as he discussed the recent bounce in software stocks. Inquiring about the stock, a caller mentioned that they consider it a spec. In response, Cramer said: Yeah, it’s alopecia. Okay, here’s the problem with that: never been solved. Always supposed to be right around the corner. It’s a very risky stock. But I have to tell you, if it can be solved, it’s worth double. So it’s double or nothing with MANE. Image by Sergei Tokmak ...